Clinical characteristics of the response to β-interferon in relapsing-remitting Multiple Sclerosis from the Burgundy MS database

被引：0
|
作者：
Fromont, A [1 ]
Le Teuff, G [1 ]
Couvreur, G [1 ]
Dumas, R [1 ]
Giroud, M [1 ]
Quantin, C [1 ]
Moreau, T [1 ]
机构：
[1] Ctr Hosp Univ, Dijon, France
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [1] Clinical characteristics of nonresponders to interferon beta therapy for relapsing-remitting multiple sclerosis
    Waubant, E
    Vukusic, S
    Confavreux, C
    [J]. NEUROLOGY, 2002, 58 (07) : A189 - A190
  • [2] Clinical predictors of response to interferon-β therapy in relapsing-remitting multiple sclerosis
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S237 - S238
  • [3] Clinical predictors of response to interferon beta in relapsing-remitting multiple sclerosis from an East France cohort
    Fromont, A
    Debouverie, M
    Couvreur, G
    Moreau, T
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S157 - S157
  • [4] Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
    Río, J
    Nos, C
    Tintoré, M
    Téllez, N
    Galán, I
    Pelayo, R
    Comabella, M
    Montalban, X
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (02) : 344 - 352
  • [5] Clinical and demographic characteristics of relapsing-remitting multiple sclerosis in Kazakhstan
    Kozhakanova, S.
    Almakhanova, K.
    Zhusupova, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 750 - 751
  • [6] In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim
    Fianne L. P. Sips
    Francesco Pappalardo
    Giulia Russo
    Roberta Bursi
    [J]. BMC Medical Informatics and Decision Making, 22
  • [7] In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim
    Sips, Fianne L. P.
    Pappalardo, Francesco
    Russo, Giulia
    Bursi, Roberta
    [J]. BMC MEDICAL INFORMATICS AND DECISION MAKING, 2022, 22 (SUPPL 6)
  • [8] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    [J]. PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [9] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
  • [10] Is interferon effective and safe for relapsing-remitting multiple sclerosis?
    Filippini, G
    Incorvaia, B
    [J]. NEUROEPIDEMIOLOGY, 2002, 21 (06) : 310 - 310
12345